Marker Therapeutics (MRKR) Financials: Revenue & Earnings

MRKR price $0.99 +0.04 +4.39%

Ticker
MRKR
Price
$0.99
Change
+0.04 +4.39%
Market cap ?
$16.56M
Beta ?
1.53
Sector
Healthcare
Industry
Biotechnology

Fair value

MRKR fair value $11.19. Price $0.99. Price is 91% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 1.62M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 1.5). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 16.67M. Net debt -16.07M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare MRKR

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-12—-0.12—2.12M
2026-08-14-0.09-0.13700.00K660.67K
2026-05-15-0.16-0.18800.00K783.90K
2026-03-18-0.10-0.211.10M682.10K
2025-11-13-0.12-0.361.23M723.00K
2025-08-14-0.29-0.30861.18K430.60K
2025-05-15-0.40-0.66349.10K174.55K
2025-03-31-0.42-0.222.25M1.22M
2024-11-14-0.26-0.391.93M1.00M
2024-08-14-0.29-0.431.17M—
2024-05-15-0.27-0.251.24M—
2024-03-26-0.48-1.001.06M—
2023-11-09-0.34-0.90257.61K—
2023-08-14-0.47-0.80762.66K—
2023-05-16-0.570.801.23M—
2023-03-22-0.48-1.00759.14K270.00K
2022-11-10-0.80-1.20999.57K400.00K
2022-08-11-1.10-1.27790.51K2.50M
2022-05-13-1.20-1.33964.32K1.00M
2022-03-17-1.20-1.271.24M—
2021-11-10-1.20-1.27——
2021-08-10-1.30-1.17——
2021-05-12-1.60-1.45——
2021-03-09-1.80-1.600—
2020-11-09-1.60-1.43——
2020-08-10-1.40-1.42466.79K466.79K
2020-05-11-1.40-1.14——
2020-03-12-1.10-1.26213.19K251.96K
2019-11-12-1.20-1.32——
2019-08-08-1.20-1.28——
2019-05-09-1.20-1.70——
2019-03-15-6.40-2.106—
2018-11-13-3.20-4.40——
2018-08-09-4.07—205.99K—
2018-05-15-3.01———
2018-03-23-3.00-5.00——
2017-11-14-3.90—183.06K—
2017-08-07-2.21———
2017-05-05-2.87———
2017-03-14-1.78———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2025-11-17Knobil KatharineBuy137.33K$0.95131.12K
2025-11-17Knobil KatharineBuy84.41K$0.9580.60K
2025-11-17Eansor Norman DavidBuy137.33K$0.95131.12K
2025-11-17Eansor Norman DavidBuy84.41K$0.9580.60K
2025-11-17ELMS STEVEBuy137.33K$0.95131.12K
2025-11-17ELMS STEVEBuy84.41K$0.9580.60K
2025-10-31Corzo Kathryn PenkusBuy147.61K$0.99145.80K
2025-10-31Vera JuanBuy250.00K$0.99246.93K
2025-10-31Corzo Kathryn PenkusOther0——
2025-02-12ELMS STEVEBuy30.00K$1.5947.70K
2025-02-12Knobil KatharineBuy30.00K$1.5947.70K
2025-02-12Eansor Norman DavidBuy30.00K$1.5947.70K
2025-02-12Vera JuanBuy50.00K$1.5979.50K
2024-12-23ELMS STEVEBuy11.09K$3.2035.47K
2024-12-23New Enterprise Associates 16, L.P.Buy554.25K$3.201.77M
2023-06-30Lurier Eliot MOther0——
2023-06-06Eansor Norman DavidBuy8.00K$1.7213.76K
2023-06-06Knobil KatharineBuy8.00K$1.7213.76K
2023-06-06Wilson John RobertBuy8.00K$1.7213.76K
2023-06-06ELMS STEVEBuy8.00K$1.7213.76K
2023-05-10Vera JuanBuy100.00K$1.42142.00K
2023-02-27Hoang Tsvetelina PBuy33.16K$2.1470.96K
2023-02-27Koneru MythiliBuy51.92K$2.14111.10K
2023-02-27Loiacono MichaelBuy38.48K$2.1482.35K
2023-02-27Vera JuanBuy46.49K$2.1499.48K
2023-02-27Szymanska AnnaBuy29.95K$2.1464.09K
2023-02-27Agopyan NadiaBuy34.15K$2.1473.09K
2022-05-24Wilson John RobertBuy80.00K——
2022-05-24Laskow-Pooley DavidBuy80.00K——
2022-05-24Knobil KatharineBuy80.00K$0.3427.02K
2022-05-24Knobil KatharineBuy80.00K——
2022-05-24ELMS STEVEBuy80.00K——
2022-05-24ELMS STEVEBuy80.00K$0.3427.02K
2022-05-24Eansor Norman DavidBuy80.00K——
2022-05-24Eansor Norman DavidBuy80.00K$0.3427.02K
2022-03-24Hoang Peter L.Buy199.09K——
2022-03-24Hoang Peter L.Sell48.38K$0.4823.45K
2022-03-24Vera JuanBuy140.82K——
2022-03-24Vera JuanSell33.47K$0.4816.22K
2022-03-24Kim Anthony H.Buy150.51K——
2022-03-24Kim Anthony H.Sell36.08K$0.4817.49K
2022-02-17Hoang Peter L.Buy430.00K$0.46197.80K
2022-02-17Vera JuanBuy160.00K$0.4673.60K
2022-02-17Szymanska AnnaBuy40.00K$0.4618.40K
2022-02-17Loiacono MichaelBuy140.00K$0.4664.40K
2022-02-17Koneru MythiliBuy160.00K$0.4673.60K
2022-02-17Kim Anthony H.Buy160.00K$0.4673.60K
2022-02-17Hoang Tsvetelina PBuy40.00K$0.4618.40K
2022-02-17Garrett GeraldBuy40.00K$0.4618.40K
2022-02-17Agopyan NadiaBuy40.00K$0.4618.40K
2021-12-08Knobil KatharineBuy125.00K$1.20150.00K
2021-12-08Knobil KatharineOther0——
2021-06-08Wasserman Frederick GeraldBuy12.66K——
2021-06-08Laskow-Pooley DavidBuy12.66K——
2021-06-08ELMS STEVEBuy12.66K——
2021-06-08Eansor Norman DavidBuy12.66K——
2021-06-08Wilson John RobertBuy12.66K——
2021-05-18Wasserman Frederick GeraldBuy10.00K$2.4124.10K
2021-03-25Eansor Norman DavidBuy7.14K——
2021-03-25Eansor Norman DavidSell14.29K——
2021-03-16Eansor Norman DavidBuy14.29K$17.50249.99K
2021-03-16Walker Paul EdwardBuy5.71M$1.7510.00M
2021-03-16Sonsini Peter W.Buy5.71M$1.7510.00M
2021-03-16SANDELL SCOTT DBuy5.71M$1.7510.00M
2021-03-16MAKOWER JOSHUABuy5.71M$1.7510.00M
2021-03-16Makhzoumi MohamadBuy5.71M$1.7510.00M
2021-03-16Florence Anthony A. Jr.Buy5.71M$1.7510.00M
2021-03-16Chang CarmenBuy5.71M$1.7510.00M
2021-03-16Behbahani AliBuy5.71M$1.7510.00M
2021-03-16BASKETT FORESTBuy5.71M$1.7510.00M
2021-03-16New Enterprise Associates 16, L.P.Buy5.71M$1.7510.00M
2021-03-16Wilson John RobertBuy1.71M$1.753.00M
2021-03-16Vera JuanBuy571.43K$1.751000.00K
2021-03-16Hoang Peter L.Buy142.86K$1.75250.00K
2021-03-16ELMS STEVEBuy1.14M$1.752.00M
2021-02-11Hoang Peter L.Buy430.00K$3.061.32M
2021-02-10Vera JuanBuy140.00K$3.29460.60K
2021-02-10Szymanska AnnaBuy40.00K$3.29131.60K
2021-02-10Loiacono MichaelBuy140.00K$3.29460.60K
2021-02-10Koneru MythiliBuy140.00K$3.29460.60K
2021-02-10Kim Anthony H.Buy160.00K$3.29526.40K
2021-02-10Hoang Tsvetelina PBuy40.00K$3.29131.60K
2021-02-10Garrett GeraldBuy40.00K$3.29131.60K
2021-02-10Agopyan NadiaBuy40.00K$3.29131.60K
2020-12-31Wilson John RobertOther0——
2020-12-31Wasserman Frederick GeraldOther0——
2020-12-31Laskow-Pooley DavidOther0——
2020-12-31ELMS STEVEOther0——
2020-12-31ELMS STEVEOther0——
2020-12-31Eansor Norman DavidOther0——
2020-11-09Eastern Capital LTDOther0——
2020-06-16Eastern Capital LTDSell416.67K$15.006.25M
2020-05-19Wilson John RobertBuy17.02K——
2020-05-19Wasserman Frederick GeraldBuy17.02K——
2020-05-19Laskow-Pooley DavidBuy17.02K——
2020-05-19ELMS STEVEBuy17.02K——
2020-05-19Eansor Norman DavidBuy17.02K——
2020-03-10Hoang Peter L.Buy388.80K$2.12824.26K
2020-03-10Hoang Peter L.Buy41.20K$2.1287.34K
2020-03-10Vera JuanBuy113.40K$2.12240.41K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 35, holders -1 vs prior quarter. Ownership 20.55%.

HolderSharesChangeChange %Value
NEA MANAGEMENT COMPANY, LLC1.63M00.00%2.39M
BLUE OWL CAPITAL HOLDINGS LP554.25K00.00%814.75K
VANGUARD CAPITAL MANAGEMENT LLC426.17K36.85K+9.47%626.47K
AISLING CAPITAL MANAGEMENT LP325.37K00.00%478.29K
RENAISSANCE TECHNOLOGIES LLC249.42K74.13K+42.29%366.65K
GEODE CAPITAL MANAGEMENT, LLC139.82K-21.09K-13.11%205.56K
OSAIC HOLDINGS, INC.112.65K19.53K+20.97%165.59K
VANGUARD FIDUCIARY TRUST CO87.27K00.00%128.28K
LPL FINANCIAL LLC83.15K100+0.12%122.23K
CONCURRENT INVESTMENT ADVISORS, LLC67.96K67.96KNew99.91K
TWO SIGMA INVESTMENTS, LP60.20K-800-1.31%88.50K
XTX TOPCO LTD45.36K-18.21K-28.65%66.67K
NORTHERN TRUST CORP34.63K8.62K+33.14%50.91K
CITADEL ADVISORS LLC32.52K32.52KNew47.80K
STATE STREET CORP20.95K00.00%30.79K
INVST, LLC18.00K-11.00K-37.93%26.46K
CREATIVE PLANNING17.31K00.00%25.45K
JANE STREET GROUP, LLC16.83K-19.47K-53.63%24.74K
ASHTON THOMAS PRIVATE WEALTH, LLC16.40K00.00%24.11K
VIRTU FINANCIAL LLC11.57K11.57KNew17.00K
FIFTH THIRD BANCORP10.00K00.00%14.70K
UBS GROUP AG8.15K-24.22K-74.82%11.98K
VANGUARD GLOBAL ADVISERS, LLC2.51K00.00%3.69K
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC2.00K00.00%2.90K
TOWER RESEARCH CAPITAL LLC (TRC)810-2.33K-74.18%1.19K

Earnings and financials

Marker Therapeutics, Inc. (MRKR) trades at $0.99, with a market cap of $16.56M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Marker Therapeutics (MRKR) Financials: Revenue & Earnings

MRKR$0.99+0.04 +4.39%

$16.56M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History